Skip to content

AIM Market Roundup: Empyrean Energy, Indus Gas, MyHealthChecked

AIM Market Roundup: Empyrean Energy, Indus Gas, MyHealthChecked

Another day of modest losses on AIM with the junior index diverging from the gains seen on the main board. At the bell, the All Share Index was almost three points lower at 769.23.

  • Empyrean Energy +435%
  • Indus Gas +45%
  • MyHealthChecked +28%
  • Artemis Resources -33%
  • Metals One -25%

Empyrean Energy LON:EME added a hulking 435% on the day following news that it had signed a gas sale agreement with Indonesia’s PLN. 100% of the gas produced will be sold at the referenced price which is linked to underlying oil, rather than the usual fixed domestic offtake price. Whilst the gain is impressive, the share price has simply returned to the level last seen in May.


Indus Gas LON:INDI was 45% higher. There’s no news, not a lot of volume and a wide spread here so possibly just a case that the EME move has reminded some that if expected news drops correctly, could Indus soar, too?

MyHealthChecked LON:MHC gets the notable mention, up 28%. The company announced a supply agreement with Boots for a range of lateral flow self-test kits as well as lab tests which will be marketed under the Boots name. Aside from this being a 12 month deal, there are few other details here.

Artemis Resources [LON:ARV] was 33% lower following news of a capital raise. The company also saw its shares suspended on the ASX listing to account for this.

Metals One [LON:MET1] dropped 25% on the day, extending the week’s losses in the process. The market seems to have failed to price in any upside off the back of a recent acquisition in Scandinavia, with the malaise building as a result. The shares sit at 4 week lows.

That’s a wrap on our AIM roundup for the summer break. We’ll be back at the start of August.

This article does not constitute investment advice.  Do your own research or consult a professional advisor.

Share this article

Invest with these platforms

Interactive Brokers eToro Charles Stanley Hargreaves Lansdown IG
Interactive Brokers eToro Charles Stanley

Looking for great investing ideas? Get our free newsletter

Learn with our free 'How to' Guides

Our latest in-depth reports

On the podcast

Sign up for great investing stock tips

Thanks to our Site Partners

Our partners are established, regulated businesses and we are grateful for their support.

aberdeen
CME Group
FP Markets
Schroders

Pepperstone
WisdomTree
eToro
ARK

Back To Top